| Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2492 | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2155 | 2020 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 443 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 339 | 2021 |
| Long‐term safety and efficacy of eculizumab in generalized myasthenia gravis S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... Muscle & nerve 60 (1), 14-24, 2019 | 187 | 2019 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 129 | 2022 |
| Epigenome-wide association study of COVID-19 severity with respiratory failure MC de Moura, V Davalos, L Planas-Serra, D Alvarez-Errico, C Arribas, ... EBioMedicine 66, 2021 | 105 | 2021 |
| GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19 E Pairo-Castineira, K Rawlik, AD Bretherick, T Qi, Y Wu, I Nassiri, ... Nature 617 (7962), 764-768, 2023 | 59 | 2023 |
| Eculizumab improves fatigue in refractory generalized myasthenia gravis H Andersen, R Mantegazza, JJ Wang, F O’Brien, K Patra, JF Howard Quality of life research 28, 2247-2254, 2019 | 46 | 2019 |
| ‘Minimal symptom expression’in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab J Vissing, S Jacob, KP Fujita, F O’Brien, JF Howard Journal of neurology 267 (7), 1991-2001, 2020 | 36 | 2020 |
| Levobupivacaine vs. racemic bupivacaine in peribulbar anaesthesia: a randomized double blind study in ophthalmic surgery. E Pacella, S Collini, F Pacella, DC Piraino, V Santamaria, RA DE BLASI European Review for Medical & Pharmacological Sciences 14 (8), 2010 | 32 | 2010 |
| Biallelic PI4KA variants cause a novel neurodevelopmental syndrome with hypomyelinating leukodystrophy E Verdura, A Rodríguez-Palmero, V Vélez-Santamaria, L Planas-Serra, ... Brain 144 (9), 2659-2669, 2021 | 28 | 2021 |
| Diagnosis of genetic white matter disorders by singleton whole-exome and genome sequencing using interactome-driven prioritization A Schlüter, A Rodríguez-Palmero, E Verdura, V Vélez-Santamaría, M Ruiz, ... Neurology 98 (9), e912-e923, 2022 | 20 | 2022 |
| Consistent improvement with eculizumab across muscle groups in myasthenia gravis R Mantegazza, FL O'Brien, M Yountz, JF Howard Jr, REGAIN Study Group, ... Annals of clinical and translational neurology 7 (8), 1327-1339, 2020 | 20 | 2020 |
| Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study H Murai, A Uzawa, Y Suzuki, T Imai, H Shiraishi, H Suzuki, M Okumura, ... Journal of the neurological sciences 407, 116419, 2019 | 20 | 2019 |
| Intracameral lidocaine as supplement to classic topical anesthesia for relieving ocular pain in cataract surgery M Nebbioso, ML Livani, V Santamaria, A Librando, M Sepe International journal of ophthalmology 11 (12), 1932, 2018 | 19 | 2018 |
| Expanding the clinical and genetic spectrum of PCYT2-related disorders V Vélez-Santamaría, E Verdura, C Macmurdo, L Planas-Serra, A Schlüter, ... Brain 143 (9), e76-e76, 2020 | 16 | 2020 |
| Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study ZA Siddiqi, RJ Nowak, T Mozaffar, F O'Brien, M Yountz, F Patti, ... Muscle & nerve 64 (6), 662-669, 2021 | 14 | 2021 |
| Dorzolamide chlorhydrate versus acetazolamide in the management of chronic macular edema in patients with retinitis pigmentosa: description of three case reports E Pacella, L Arrico, V Santamaria, P Turchetti, MR Carbotti, G La Torre, ... Ophthalmology and eye Diseases 6, OED. S13617, 2014 | 13 | 2014 |
| Differential activity and clinical utility of latanoprost in glaucoma and ocular hypertension F Pacella, P Turchetti, V Santamaria, D Impallara, G Smaldone, ... Clinical Ophthalmology, 811-815, 2012 | 11 | 2012 |
